Holen Sie sich die Stockscreener-App
0.00
100.00%
-63.48
Handel nachbörslich:
63.50
63.50
+
Schlusskurs vom Vortag:
$63.48
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$11.52B
Einnahmen:
$4.42B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
0.00
EPS:
-2.27
Netto-Cashflow:
$99.00M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$63.50
Catalent Inc Stock (CTLT) Company Profile
Firmenname
Catalent Inc
Sektor
Telefon
(732) 537-6200
Adresse
14 SCHOOLHOUSE ROAD, SOMERSET, NJ
Vergleichen Sie CTLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTLT
Catalent Inc
|
0.00 | 11.52B | 4.42B | -413.00M | 99.00M | -2.27 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Catalent Inc Stock (CTLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-16 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-09-05 | Hochstufung | Argus | Hold → Buy |
| 2023-07-20 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-06-14 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-05-15 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-05-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-04-17 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-04-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-04-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-19 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-11-07 | Herabstufung | Argus | Buy → Hold |
| 2022-11-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-16 | Eingeleitet | Barclays | Overweight |
| 2020-12-10 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-06-25 | Eingeleitet | Argus | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Hold |
| 2019-10-17 | Fortgesetzt | Stephens | Overweight |
| 2019-08-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-06-21 | Hochstufung | Jefferies | Hold → Buy |
| 2019-04-16 | Hochstufung | UBS | Neutral → Buy |
| 2018-11-07 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-03-28 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-21 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-02-06 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2017-09-21 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-13 | Eingeleitet | Needham | Hold |
| 2017-09-08 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2016-12-01 | Eingeleitet | Goldman | Neutral |
| 2016-10-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-06-21 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-06-20 | Hochstufung | BofA/Merrill | Neutral → Buy |
Alle ansehen
Catalent Inc Aktie (CTLT) Neueste Nachrichten
Catalent to Support Galapagos’ Decentralized CAR-T Therapy Trials - Contract Pharma
Catalent, Inc. (NYSE:CTLT) Given Average Rating of “Hold” by Analysts - Defense World
StockNews.com Begins Coverage on Catalent (NYSE:CTLT) - Defense World
Novo Holdings looks to double Catalent size with eye on Trump US manufacturing focus - Yahoo Finance
JPM 2025: Thermo Fisher ‘very positive’ on sterile demand as Catalent takes capacity out of market - Pharmaceutical Technology
Catalent (NYSE:CTLT) Now Covered by Analysts at StockNews.com - Defense World
Novo Holdings completes purchase of Catalent - MSN
Catalent (NYSE:CTLT) Coverage Initiated by Analysts at StockNews.com - Defense World
JPMorgan Chase & Co. Acquires 199,427 Shares of Catalent, Inc. (NYSE:CTLT) - Defense World
Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty - MSN
Trump Nominates Olivia Trusty for FCC Commissioner Role Ahead of Inauguration - PYMNTS.com
Principal Financial Group Inc. Has $12.61 Million Position in Catalent, Inc. (NYSE:CTLT) - Defense World
Catalent, Inc. (NYSE:CTLT) Receives Consensus Rating of “Hold” from Brokerages - Defense World
MML Investors Services LLC Has $442,000 Stake in Catalent, Inc. (NYSE:CTLT) - Defense World
Staff AccountantCatalent, Inc. - Built In
Novo Nordisk Set to Close Catalent Deal Without FTC Challenge - MSN
Novo Holdings completes $16.5 billion takeover of Catalent - MSN
Novo Holdings says its acquisition of Catalent is complete. - The Herald-Times
Novo Holdings Strengthens Pharma Standing With Catalent Acquisition - Finimize
Catalent, Inc Announces Board Changes - Marketscreener.com
Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say - MSN
Novo Holdings closes $16.5 billion buyout of contract manufacturer Catalent - MSN
Novo Holdings completes Catalent acquisition for $16.5bn - Yahoo Finance
Lennox To Join S&P 500 Index, Replacing Catalent - Yahoo! Voices
This industrials company is joining the S&P 500 soon - MSN
Novo Holdings completes $16.5B acquisition of Catalent - Inside INdiana Business
Novo Completes $16.5 Billion Acquisition of Catalent - Yahoo Finance
Novo Holdings Completes Acquisition of Catalent - citybiz
Catalent Acquired by Novo Holdings in $16.5 Billion Deal - TipRanks
Novo Holdings Finalizes $16.5 Billion Acquisition of CatalentNews and Statistics - IndexBox, Inc.
Catalent : Novo Holdings Completes Acquisition of Catalent Form 8 K - Marketscreener.com
Catalent acquired by Novo Holdings for $16.5 billion - Investing.com
Novo Holdings has completed the acquisition of Catalent - Marketscreener.com
The acquisition of Catalent by Novo Holdings, and the - GlobeNewswire
The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed - Yahoo Finance UK
Novo Holdings Completes Massive $16.5B Catalent Acquisition, Offering 47.5% Premium to Shareholders - StockTitan
Novo Nordisk Invests $1.2 Billion in New Denmark Factory, Fresh Off Catalent Deal - geneonline
Catalent wins EU approval for planned $16.5B sale to Novo Holdings - MSN
Novo Nordisk’s New Deal May End Wegovy Shortages. It Could Reshape Pharma Industry Along the Way. - Barron's
Danish pharma giant cleared to buy Catalent - Indiana Public Media
House Panel Accuses Financial Firms of Collusion Over ESG Goals - PYMNTS.com
Novo Holdings Completes Regulatory Hurdles For Catalent Acquisition - Contract Pharma
Novo Holdings’ $16.5B deal for Catalent clears last regulatory hurdle - MM+M Online
Finanzdaten der Catalent Inc-Aktie (CTLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):